Search

Search Results
Results 4451 - 4460 of 4658 for Clear Cell Cancer
  • Health Canada approves Zyclara Cream for multiple actinic keratoses
    News - 6 Jan 2010
    Health Canada has approved Zyclara™ (imiquimod) Cream 3.75%, a topical prescription treatment for multiple actinic keratoses (AK) located on the face or balding scalp in adults. Actinic Keratosis is a...
  • Positive Phase 2 study results of CDX-011 reported by Celldex Therapeutics
    News - 13 Dec 2009
    Celldex Therapeutics, Inc. today announced the results of a positive Phase 2 study of CDX-011 (formerly CR011-vcMMAE), in patients with heavily pre-treated, locally advanced or metastatic breast...
  • Enbrel shown to significantly reduced levels of C-reactive protein
    News - 5 Feb 2008
    Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation,...
  • Research findings link weight gain and diabetes to a variety of cancers
    News - 10 Dec 2007
    During this holiday season with its tempting bounty of edible delights, new research calls attention to the role of the expanding American waistline in health and medicine.
  • Improvements in cancer survival in Northern Ireland
    News - 4 Oct 2007
    There have been improvements in cancer survival in Northern Ireland between 1993 and 2004, according to a new report from the Northern Ireland Cancer Registry (NICR), launched at Queen’s today.
  • Chernobyl: The True Scale of the Accident
    News - 5 Sep 2005
    A total of up to four thousand people could eventually die of radiation exposure from the Chernobyl nuclear power plant (NPP) accident nearly 20 years ago, an international team of more than 100...
  • Severe Acute Respiratory Syndrome (SARS) overview
    News - 24 Apr 2004
    Severe Acute Respiratory Syndrome (SARS) is an atypical form of pneumonia that first appeared in November 2002 in Guangdong Province, China.
  • Columvi
    Drug - 28 May 2026
    Consumer Medicine Information (CMI) about Columvi intended for persons living in Australia.
  • Lemtrada
    Drug - 18 May 2026
    Consumer Medicine Information (CMI) about Lemtrada intended for persons living in Australia.
  • Evoltra
    Drug - 5 May 2026
    Consumer Medicine Information (CMI) about Evoltra intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback